Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability

Raghuvir Keni, Pawan Ganesh Nayak, Nitesh Kumar, Anoop Kishore, Sulaiman Mohammed Alnasser, Farmiza Begum, Karthik Gourishetti, Krishnadas Nandakumar

Research output: Contribution to journalArticlepeer-review

Abstract

Statin-associated diabetes (SAD) is an issue that has come to light after a series of recent clinical trials that has led to the issue of a black box warning for statins by the US FDA. However, the benefit of statin outweighs its risk. Nevertheless, experiments have been conducted to identify the mechanism by which statins aggravate the risk of diabetes only in a select population who bear the risk factors of obesity, sedentary lifestyle, hypertension, and other associated risk factors of lifestyle disorders. In this study, the possibility of utilization of a phyto-molecule, sesamol, for its ability to combat statin-associated diabetes using atorvastatin as the agent of choice has been explored. MMP assay and western blot was conducted to investigate the effects of atorvastatin on apoptotic cascade with sesamol as a protective agent was conducted in MIN-6 cells. Effect of the combination was tested in L6 cells with 2-NBDG uptake assay and as well as western blot for GLUT-4. A diet-induced hypercholesterolemia model was developed in an in vivo model animals and treated with atorvastatin and sesamol with histopathological analysis being carried out to evaluate the apoptotic markers and GLUT-4 presence. It was found that sesamol can combat pancreatic beta cell apoptosis via the internal apoptotic pathway activated by atorvastatin. With regards to muscle cells, sesamol could improve the GLUT-4 vesical production, but not improve glucose uptake which is inhibited by atorvastatin. These findings are further confirmed by animal studies. These findings indicate that sesamol can serve as a prototype molecule for further development and investigation of similar compounds to tackle SAD.

Original languageEnglish
Article number377
Journal3 Biotech
Volume13
Issue number11
DOIs
Publication statusPublished - 11-2023

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Environmental Science (miscellaneous)
  • Agricultural and Biological Sciences (miscellaneous)

Fingerprint

Dive into the research topics of 'Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability'. Together they form a unique fingerprint.

Cite this